Japanese Society of Clinical Neuropsychopharmacology

As President of the Japanese Society of Clinical Neuropsychopharmacology (JSCNP), I am honored to extend my formal greetings. In October 2024, I was appointed as the 12th President of JSCNP. Together with Vice President Koichiro Watanabe, the Board of Directors, councilors, and society members, I am committed to advancing the Society’s objectives and fostering its continued development.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore organization profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Japanese Society of Clinical Neuropsychopharmacology.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

As President of the Japanese Society of Clinical Neuropsychopharmacology (JSCNP), I am honored to extend my formal greetings. In October 2024, I was appointed as the 12th President of JSCNP. Together with Vice President Koichiro Watanabe, the Board of Directors, councilors, and society members, I am committed to advancing the Society’s objectives and fostering its continued development.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.